No Data
No Data
Haemonetics' (NYSE:HAE) Earnings Offer More Than Meets The Eye
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $90 to $115
Haemonetics Price Target Cut to $100.00/Share From $125.00 by JMP Securities
Haemonetics Is Maintained at Market Outperform by JMP Securities
HAE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket
Haemonetics Third Quarter 2025 Earnings: Misses Expectations